Abilify Withdrawal
Links shared publicly online about this topic
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
medicalnewstoday.com — “The european medicines agency has been formally notified by otsuka pharmaceutical europe ltd of its decision to withdraw its application for an extension of indication for the centrally authorised” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 11:41 am By:
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripipra.. http://bit.ly/1QCH4R
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Mental Health
The latest mental health news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
